Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.24.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2024
Jan. 31, 2023
Income Statement [Abstract]        
Revenues $ 8,553 $ 7,514 $ 16,359 $ 14,617
Operating costs and expenses:        
Cost of revenues 4,329 4,616 8,680 9,205
Research and development 580 1,125 1,429 1,824
Selling, general and administrative 5,068 5,430 12,070 10,866
Legal and related expense, net 761 888 1,835 1,895
Total operating costs and expenses 10,738 12,059 24,014 23,790
Operating loss (2,185) (4,545) (7,655) (9,173)
Other income (expense):        
Interest, net 893 63 1,870 135
Change in fair value of convertible debentures (383) (711)  
Other 119 118 276 118
Foreign exchange gain (loss) 693 1,472 (318) 675
Total other income (expense) 1,322 1,653 1,117 928
Loss before income taxes (863) (2,892) (6,538) (8,245)
Income taxes    
Net loss from continuing operations (863) (2,892) (6,538) (8,245)
Net loss from discontinued operations (2,198) (8,428) (3,139) (13,710)
Net loss $ (3,061) $ (11,320) $ (9,677) $ (21,955)
Net loss per common share – basic and diluted:        
Continuing operations (in Dollars per share) $ (0.02) $ (0.06) $ (0.13) $ (0.17)
Discontinued operations (in Dollars per share) (0.04) (0.17) (0.06) (0.28)
Total net loss per basic and diluted common share (in Dollars per share) $ (0.06) $ (0.23) $ (0.19) $ (0.45)
Weighted average common shares outstanding:        
Basic (in Shares) 50,490 48,729 50,337 48,725